Takeda 2.3 mg (Ninlaro 2.3 mg)
Generic Name: ixazomib
Pill with imprint Takeda 2.3 mg is Pink, Capsule-shape and has been identified as Ninlaro 2.3 mg. It is supplied by Takeda Pharmaceutical Company Limited.
Ninlaro is used in the treatment of multiple myeloma and belongs to the drug class proteasome inhibitors. Ninlaro 2.3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Takeda 2.3 mg
Ninlaro
- Generic Name
- ixazomib
- Imprint
- Takeda 2.3 mg
- Strength
- 2.3 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Proteasome inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 63020-0078
More about Ninlaro (ixazomib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: proteasome inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.